# Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)

> **NCT06110910** · — · RECRUITING · sponsor: **Xiaoping Luo** · enrollment: 10000 (estimated)

## Conditions studied

- Childhood Short Stature

## Interventions

- **DRUG:** Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) or recombinanthuman growth hormone injection (rhGH)

## Key facts

- **NCT ID:** NCT06110910
- **Lead sponsor:** Xiaoping Luo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06110910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06110910, "Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06110910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*